Live feed
·
INSIDERFilingvia Quantisnow
Alexion Pharmaceuticals, Inc. logo

SEC Form 4: SARIN ARADHANA was granted 56,313 units of Common Stock, increasing direct ownership by 88% to 120,253 units

ByQuantisnow·Wall Street's wire, on your screen.
Stocks in this Quantisnow insight
Quantisnow market dataNASDAQ
Alexion Pharmaceuticals, Inc. logo
ALXN
Alexion Pharmaceuticals, Inc.
Market cap
30-day
Sector
Health Care
Industry
Major Pharmaceuticals
Listed since
1996
Follow ALXNFull ALXN profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ALXN (Alexion Pharmaceuticals, Inc.) and more on Quantisnow.